These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 26247832)

  • 21. [Correlation between serum inhibin B level after treatment with gonadotropin releasing hormone agonist and outcome of in vitro fertilization-embryo transfer].
    Lin WQ; Yang HY; Lin JJ; Chen X; Ye BL
    Zhonghua Fu Chan Ke Za Zhi; 2009 Apr; 44(4):260-2. PubMed ID: 19570462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluating the benefit of measuring serum progesterone prior to the administration of HCG: effect of the duration of late-follicular elevated progesterone following ovarian stimulation on fresh embryo transfer live birth rates.
    Santos-Ribeiro S; Racca A; Roelens C; De Munck N; Mackens S; Drakopoulos P; Tournaye H; Blockeel C
    Reprod Biomed Online; 2019 Apr; 38(4):647-654. PubMed ID: 30593439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Premature Progesterone Rise Positively Correlates with Clinical Pregnancy Rate in In Vitro Fertilization (IVF) and Intracytoplasmic Sperm Injection (ICSI) Patients with good Ovarian Response.
    Cui N; Zhang J; Xu Y; Jiang L; Yang A; Hao G
    Horm Metab Res; 2017 May; 49(5):372-379. PubMed ID: 28351088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated progesterone in GnRH agonist down regulated in vitro fertilisation (IVFICSI) cycles reduces live birth rates but not embryo quality.
    Lahoud R; Kwik M; Ryan J; Al-Jefout M; Foley J; Illingworth P
    Arch Gynecol Obstet; 2012 Feb; 285(2):535-40. PubMed ID: 21853250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparison of GnRH antagonist fixed protocol and GnRH agonists long protocol in infertile patients with normal ovarian reserve function in their first in vitro fertilization-embryo transfer cycle].
    Yang S; Chen XN; Qiao J; Liu P; Li R; Chen GA; Ma CH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):245-9. PubMed ID: 22781108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical applications of different doses of leuprorelin acetate in in vitro fertilization-embryo transfer].
    Wang L; Zhang WX; Jiang H
    Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):910-4. PubMed ID: 23324190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The addition of gonadotrophin releasing hormone agonist to routine luteal phase support in intracytoplasmic sperm injection and embryo transfer cycles: a randomized clinical trial.
    Yıldız GA; Şükür YE; Ateş C; Aytaç R
    Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():66-70. PubMed ID: 25238659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Basal progesterone level as the main determinant of progesterone elevation on the day of hCG triggering in controlled ovarian stimulation cycles.
    Papaleo E; Corti L; Vanni VS; Pagliardini L; Ottolina J; De Michele F; La Marca A; Viganò P; Candiani M
    Arch Gynecol Obstet; 2014 Jul; 290(1):169-76. PubMed ID: 24549270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human recombinant luteinizing hormone is as effective as, but safer than, urinary human chorionic gonadotropin in inducing final follicular maturation and ovulation in in vitro fertilization procedures: results of a multicenter double-blind study.
    European Recombinant LH Study Group
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2607-18. PubMed ID: 11397861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High ovarian response does not jeopardize ongoing pregnancy rates and increases cumulative pregnancy rates in a GnRH-antagonist protocol.
    Fatemi HM; Doody K; Griesinger G; Witjes H; Mannaerts B
    Hum Reprod; 2013 Feb; 28(2):442-52. PubMed ID: 23136144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subtle progesterone rise in the single-dose gonadotropin-releasing hormone antagonist (cetrorelix) stimulation protocol in patients undergoing in vitro fertilization or intracytoplasmic sperm injection cycles.
    Seow KM; Lin YH; Huang LW; Hsieh BC; Huang SC; Chen CY; Chen PH; Tzeng CR; Hwang JL
    Gynecol Endocrinol; 2007 Jun; 23(6):338-42. PubMed ID: 17616858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.
    Lin MH; Wu FS; Lee RK; Li SH; Lin SY; Hwu YM
    Fertil Steril; 2013 Nov; 100(5):1296-302. PubMed ID: 23993928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Premature progesterone rise negatively correlated with live birth rate in IVF cycles with GnRH agonist: an analysis of 2,566 cycles.
    Huang R; Fang C; Xu S; Yi Y; Liang X
    Fertil Steril; 2012 Sep; 98(3):664-670.e2. PubMed ID: 22704632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Triggering final oocyte maturation with reduced doses of hCG in IVF/ICSI: a prospective, randomized and controlled study.
    Lin H; Wang W; Li Y; Chen X; Yang D; Zhang Q
    Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):143-7. PubMed ID: 21824709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The individualized choice of embryo transfer timing for patients with elevated serum progesterone level on the HCG day in IVF/ICSI cycles: a prospective randomized clinical study.
    Yang S; Pang T; Li R; Yang R; Zhen X; Chen X; Wang H; Ma C; Liu P; Qiao J
    Gynecol Endocrinol; 2015 May; 31(5):355-8. PubMed ID: 25558791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of endogenous luteinizing hormone serum levels on progesterone elevation on the day of human chorionic gonadotropin administration.
    Hugues JN; Massé-Laroche E; Reboul-Marty J; Boîko O; Meynant C; Cédrin-Durnerin I
    Fertil Steril; 2011 Sep; 96(3):600-4. PubMed ID: 21880277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The value of the progesterone-to-estradiol ratio on the day of hCG administration in predicting ongoing pregnancy and live birth rates in normoresponders undergoing GnRH antagonist cycles.
    Cetinkaya ES; Berker B; Aytac R; Atabekoglu C; Sonmezer M; Ozmen B
    Eur J Obstet Gynecol Reprod Biol; 2013 Oct; 170(2):452-7. PubMed ID: 23932375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recurrent IVF failure is associated with elevated progesterone on the day of hCG administration.
    Liu L; Zhou F; Lin X; Li T; Tong X; Zhu H; Zhang S
    Eur J Obstet Gynecol Reprod Biol; 2013 Nov; 171(1):78-83. PubMed ID: 24012150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High progesterone levels on the day of HCG administration do not affect the embryo quality and the reproductive outcomes of frozen embryo transfers.
    Baldini D; Savoia MV; Sciancalepore AG; Malvasi A; Vizziello D; Beck R; Vizziello G
    Clin Ter; 2018; 169(3):e91-e95. PubMed ID: 29938738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.